FOLFIRINOX chemotherapy modulates the peripheral immune landscape in pancreatic cancer: implications for combination therapies and early response prediction

This study investigates the impact of FOLFIRINOX on plasma proteins and peripheral immune cells to guide immune-based combination therapies and, ideally, to identify a potential biomarker to predict early disease progression during FOLFIRINOX.

Source: European Journal of Cancer - November 16, 2023 Category: Cancer & Oncology Authors: Casper W.F. van Eijck, Gaby Strijk, Eveline E. Vietsch, Fleur van der Sijde, Maaike Verheij, Dana Mustafa, Madelief Vink, Joachim G.J.V. Aerts, Casper H.J. van Eijck, Marcella Willemsen Tags: Original Research Source Type: research